PBAC Public Summary Documents – May 2023
Page last updated: 30 August 2023
The following Public Summary Documents have been updated at the May 2023 PBAC meeting:
March 2023 PBAC meeting
- Carmellose with glycerin and with hyaluronic acid: Eye drops containing carmellose sodium 5 mg with glycerin 9 mg and with hyaluronic acid 1 mg per mL, 10 mL; Optive Fusion® – March 2023
- Hyaluronic acid with polyethylene glycol 400 with propylene glycol with hydroxypropyl guar: Eye drops containing sodium hyaluronate 1.5 mg per mL with polyethylene glycol 400, propylene glycol and hydroxypropyl guar, 10 mL; Systane® Hydration – March 2023
- Inclisiran: Injection 284 mg in 1.5 mL single use pre-filled syringe; Leqvio® – March 2023
